Cupps Capital Management’s TransDigm Group TDG Stock Holding History

Cupps Capital Management’s Portfolio TDG Stock Details TDG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,235	Closed	-$242K	–	234
2014 Q4	$242K	Buy	+1,235	New	+$233K	0.02%	170

Other funds holding TDG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Berkshire Partners Boston, Massachusetts $4.96M AUM 59.38% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.75B AUM 18.52% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Cupps Capital Management's TDG Position: Q1 2015 in Review

Cupps Capital Management sold out of TransDigm Group (TDG) in Q1 2015, closing a stake of 1,235 shares — an estimated $242K sold.

Cupps Capital Management first reported a position in TDG in Q4 2014 and held it in 1 quarter. The position peaked at $242K in Q4 2014. 358 funds tracked by Wall St. Rank hold TDG as of Q1 2015.

Cupps Capital Management reported no remaining TransDigm Group position as of Q1 2015 after selling out during the quarter.
Cupps Capital Management sold 1,235 TransDigm Group shares in Q1 2015, an estimated $242K.
Cupps Capital Management first reported a position in TransDigm Group in Q4 2014 and held it in 1 quarter.
Cupps Capital Management's TransDigm Group position peaked at $242K in Q4 2014.
358 funds tracked by Wall St. Rank held TransDigm Group as of Q1 2015.

Based on Cupps Capital Management's 13F filing for Q1 2015, filed 13 May 2015.